Cardiovascular Diseases Research in Pennsylvania
USAspending.gov records $1,804,188,493.86 in Cardiovascular Diseases Research obligations (CFDA 93.837) with place of performance in Pennsylvania, across 917 awards. Nine hundred seventeen instruments against $1.80 billion imply about $1.97 million per award. This page joins HHS catalog 93.837 to the PA geography tag. It is not Pennsylvania CDC investigations, not a nationwide 93.837 rollup, and not Pennsylvania's entire federal spending. Obligations are not outlays.
Key figures
- CFDA 93.837 shows $1,804,188,493.86 in Pennsylvania obligations on 917 awards.
- The mean is about $1.97 million per award.
- 917 is an award-record count, not a study census.
- Pennsylvania is a place-of-performance tag, not a study, lab, or investigator census.
- Figures are obligations, not outlays.
Pennsylvania and cardiovascular research as a pair
CFDA 93.837 is titled CARDIOVASCULAR DISEASES RESEARCH. Crossed with Pennsylvania place of performance, obligations sum to $1,804,188,493.86 on 917 awards. The national 93.837 hub includes other states. Pennsylvania’s spending hub includes other programs. Only this intersection is reported here. $1,804,188,493.86 is an obligation aggregate from USAspending.gov, not an outlay and not a count of heart-disease studies in Pennsylvania.
Nine hundred seventeen awards is a extramural research file with hundreds of rows against a large sum. The join does not name recipients. Packet facts are $1,804,188,493.86, 917 awards, PA, and 93.837. Correlation is not causation. FEC donations do not fund this USAspending cell. Keep Cardiovascular Diseases Research and Pennsylvania together when reading $1,804,188,493.86.
93.837 is not CDC investigations
CDC Investigations (CFDA 93.283) in Pennsylvania is technical assistance, not this research catalog. Mixing 93.837 and 93.283 invents a combined CDC-and-heart-research book. Mixing those series into $1,804,188,493.86 would invent a broader total than this cell contains. Facts available: Pennsylvania, CFDA 93.837, $1,804,188,493.86, 917 awards. Investigator names, university names, and trial-enrollment counts are unpublished.
The catalog title names Cardiovascular Diseases Research, not a ranking of Pennsylvania medical schools. Dividing $1,804,188,493.86 by 917 yields about $1.97 million per award. Unique recipients are unpublished. 917 is not a study, lab, or investigator census.
Pennsylvania geography, not a campus roster
PA is the place-of-performance code. Awards billed to Philadelphia, Pittsburgh, or Hershey can share the tag. Awards coded to Ohio, New York, New Jersey, Maryland, Delaware, and West Virginia stay outside $1,804,188,493.86 even when activity later crosses those lines. The code does not convert $1.80 billion into a hospital research atlas.
Pennsylvania federal spending is the all-program parent. 93.837 is one row on Pennsylvania programs. $1.80 billion is not the state’s complete federal footprint. Open Cardiovascular Diseases Research in Pennsylvania for the filtered table, CFDA 93.837 for the catalog without a Pennsylvania filter, and All spending ties for other pairs. Do not add those parents into $1,804,188,493.86.
Nine hundred seventeen awards, still obligations
$1,804,188,493.86 ÷ 917 is about $1.97 million per award. That average is a low-seven-figure mean, not a median. Net obligations can include downward modifications; the total shown is the aggregate in the facts. Treat 917 as a record count, not as 917 unique studies or 917 named investigators.
Without a transaction register, you cannot see how many of the 917 rows are continuations, renewals, or corrections. Later ingests can restate $1,804,188,493.86 without changing the join key of 93.837 and PA. USAspending obligations can be positive new awards or net of downward modifications; $1,804,188,493.86 is the net total supplied in the facts. The pair remains Cardiovascular Diseases Research plus Pennsylvania. Do not treat $1,804,188,493.86 as an outlay series.
What Pennsylvania heart-disease research does not prove
A large 93.837 total tagged to Pennsylvania does not measure whether heart-disease mortality fell in Pennsylvania, and it does not equal research draws already spent. FEC donations do not fund this USAspending cell. Correlation is not causation. The headline remains $1,804,188,493.86 on 917 awards for Cardiovascular Diseases Research in Pennsylvania.
Keep both sides of the join: Cardiovascular Diseases Research and Pennsylvania, obligations only. Do not annualize $1,804,188,493.86 without a year field—this packet publishes none. Do not treat 917 as a study, lab, or investigator census. Quote USAspending.gov and the overlay path rather than a clinical-trial narrative. Cite Cardiovascular Diseases Research together with Pennsylvania whenever you reuse $1,804,188,493.86.
Citing CFDA 93.837 in Pennsylvania
The overlay target is the Pennsylvania × CFDA 93.837 table. Open Cardiovascular Diseases Research in Pennsylvania when you want the same $1,804,188,493.86 / 917-award cell in the site’s data chrome. CFDA 93.837 drops the Pennsylvania filter. Pennsylvania federal spending drops the CFDA filter. Pennsylvania programs lists other catalogs beside 93.837. All spending ties indexes other pairs.
This page exists because two tables meet: a CFDA program and a place-of-performance state. It does not exist to argue that Pennsylvania won or lost federal money, that donations paid for the awards, or that obligations equal cash. The pair is 93.837 plus PA. Obligations of $1,804,188,493.86 are not outlays. Original filings remain on USAspending.gov for this 93.837 × PA pair. 917 remains an award-record count, not a person, facility, or project census. The implied mean near $1.97 million per award is a ratio of $1,804,188,493.86 and 917 rows, typical of research project grants as a scale class, still not a median and not a named R01. Hershey folklore is ordinary speech, not extra packet dollars. Do not add TANF or disaster grants into this research cell.
Questions
- How much Cardiovascular Diseases Research is obligated in Pennsylvania?
- USAspending records $1,804,188,493.86 in CFDA 93.837 obligations with Pennsylvania place of performance on 917 awards. That is the pair total, not an outlay. Keep Cardiovascular Diseases Research and Pennsylvania together when citing $1,804,188,493.86. Original filings remain on USAspending.gov. The join is a catalog intersection, not a budget.
- Do 917 awards mean 917 Pennsylvania heart studies?
- 917 is a USAspending award-record count, not a study, lab, or investigator census. The implied mean is about $1.97 million per award. Unique recipients are unpublished. 917 is a record count, not a person or facility census. Original filings remain on USAspending.gov.
- Is this Pennsylvania's total federal research spending?
- No. This join is CFDA 93.837 only. CDC Investigations (93.283) and CHIP (93.767) are other Pennsylvania program pages. Nationwide 93.837 is not limited to Pennsylvania. Obligations of $1,804,188,493.86 are not outlays. The overlay is the live Cardiovascular Diseases Research–Pennsylvania table.
- Has this research money already been spent in labs?
- No. $1,804,188,493.86 is an obligation sum. Outlays are a different USAspending series. Drawdowns can lag the federal obligation. This packet has no outlay total. Original filings remain on USAspending.gov for this 93.837 × PA pair. Original filings remain on USAspending.gov.
USAspending.gov CFDA program aggregates by place of performance state. Obligations are not outlays.